Although alpha-fetoprotein (AFP) is commonly used as a serum biomarker for HCC detection and diagnosis, its effectiveness is restricted, and no other reliable biomarkers can facilitate precision medicine in primary liver cancer. Here, AFP is linked to hepatocellular carcinoma.